Tu1702 ACHIEVEMENT OF CORTICOSTEROID-FREE CLINICAL ENDPOINTS IN SUBJECTS WITH ULCERATIVE COLITIS: AN ANALYSIS OF THE PHASE 3 ELEVATE UC 52 TRIAL | Publicación